Hologic Ventures

Hologic Ventures is the strategic investment wing of Hologic, a global medical technology company based in Marlborough, Massachusetts. The fund concentrates on accelerating early-stage technologies dedicated to women’s and reproductive health and clinical diagnostics, mirroring Hologic’s commercial leadership in those areas. As a corporate VC, the team values financial returns alongside strategic alignment with the parent company’s product roadmap and clinical channels. AI focus is not formally indicated, although AI-enabled imaging, diagnostics, and women’s health tools fit naturally within the stated areas of interest.

Investments are made at seed and Series A stages with check sizes between $1M and $5M. Activity is global in scope due to Hologic’s international footprint, but specific geographic prioritization is not publicly detailed. The fund typically co-invests with traditional MedTech, diagnostics, and women’s health investors, contributing technical and commercial insight from Hologic’s product and clinical organizations rather than leading.

For founders, a credible engagement starts with positioning the company as a strategic complement to Hologic’s diagnostic and women’s health portfolio, ideally with a clear regulatory pathway and clinical evidence plan. AI capabilities should be tied to specific imaging, screening, or diagnostic workflows where Hologic already has commercial relevance. Limited public information is available about detailed deal preferences, so introductions through Hologic business unit leaders, women’s health clinicians, and MedTech-focused investors are the most reliable inbound paths.